Ophthalmic artery chemosurgery for the management of retinoblastoma in eyes with extensive (>50%) retinal detachment

Pediatric Blood and Cancer

Volumn 59, Issue 5, 2012, Pages 859-864

  Palioura, Sotiria ^a,d   Gobin, Y Pierre ^b   Brodie, Scott E ^a,c   Marr, Brian P ^a   Dunkel, Ira J ^a   Abramson, David H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

International Classification Group D E; Intra arterial chemotherapy; Reese Ellsworth Group V; Retinal detachment; Retinoblastoma; Systemic chemoreduction

Indexed keywords

ADRENALIN HYDROGEN TARTRATE; CARBOPLATIN; MELPHALAN; METHOTREXATE; TOPOTECAN;

ARTICLE; AVASCULAR RETINOPATHY; BRONCHOSPASM; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; CATARACT; CHEMOTHERAPY INDUCED ANEMIA; CHILD; COMPLICATION; CRYOTHERAPY; ELECTRORETINOGRAM; ENUCLEATION; EXTERNAL BEAM RADIOTHERAPY; EYE EDEMA; EYE REDNESS; EYELASH THINNING; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; INFLAMMATION; LASER SURGERY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OPHTHALMIC ARTERY; OPHTHALMIC ARTERY CHEMOSURGERY; PERIOCULAR ERYTHEMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA SURGERY; RETINOBLASTOMA; RETINOPATHY; TUMOR SEEDING;

CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; OPHTHALMIC ARTERY; OPHTHALMOLOGIC SURGICAL PROCEDURES; RETINAL DETACHMENT; RETINOBLASTOMA; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84866180571     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24170     Document Type: Article

References (42)

1. Broaddus E, Topham A, Singh AD. Incidence of retinoblastoma in the USA: 1975-2004. Br J Ophthalmol 2009; 93: 21-23.
2. Abramson DH, Schefler AC, Dunkel IJ. Neoplasms of the eye. In: Kufe DW, Bast RC, Hait W, Hong WK, Pollock RE, Weichselbaum RR, Holland JF, Frei E, editors. Holland-Frei Cancer Medicine, 7th edition. Hamilton: BC Decker; 2006. pp. 1071-1083.
3. Abramson DH, Beaverson KL, Chang ST, et al. Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma. Arch Ophthalmol 2004; 122: 1316-1323.
4. De Potter P. Current treatment of retinoblastoma. Curr Opin Ophthalmol 2002; 13: 331-336.
5. Schefler AC, Abramson DH. Retinoblastoma: What is new in 2007-2008. Curr Opin Ophthalmol 2008; 19: 526-534.
6. Abramson DH. Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: 'Chemosurgery' the first Stallard lecture. Br J Ophthalmol 2010; 94: 396-399.
7. Murphree AL, Villablanca JG, Deegan WF III, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 1996; 114: 1348-1356.
8. Friedman DL, Himelstein B, Shields CL, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 2000; 18: 12-17.
9. Cohen VM, Kingston J, Hungerford JL. The success of primary chemotherapy for group D heritable retinoblastoma. Br J Ophthalmol 2009; 93: 887-890.
10. Mallipatna AC, Sutherland JE, Gallie BL, et al. Management and outcome of unilateral retinoblastoma. J AAPOS 2009; 13: 546-550.
11. Shields CL, Honavar SG, Meadows AT, et al. Chemoreduction for unilateral retinoblastoma. Arch Ophthalmol 2002; 120: 1653-1658.
12. Shields CL, Honavar SG, Meadows AT, et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 2002; 133: 657-664.
13. Lumbroso-Le Rouic L, Aerts I, Levy-Gabriel C, et al. Conservative treatments of intraocular retinoblastoma. Ophthalmology 2008; 115: 1405-1410.
14. Schmack I, Hubbard GB, Kang SJ, et al. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma. Am J Ophthalmol 2006; 142: 310-315.
15. Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 1993; 85: 1121-1128.
16. Wong FL, Boice JD, Jr, Abramson DH, et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 1997; 278: 1262-1267.
17. Abramson DH, Melson MR, Dunkel IJ, et al. Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma. Ophthalmology 2001; 108: 1868-1876.
18. Marees T, van Leeuwen FE, de Boer MR, et al. Cancer mortality in long-term survivors of retinoblastoma. Eur J Cancer 2009; 45: 3245-3253.
19. Gombos DS, Hungerford J, Abramson DH, et al. Secondary acute myelogenous leukemia in patients with retinoblastoma: Is chemotherapy a factor? Ophthalmology 2007; 114: 1378-1383.
20. Reese AB, Ellsworth RM. The evaluation and current concept of retinoblastoma therapy. Trans Am Acad Ophthalmol Otolaryngol 1963; 67: 164-172.
21. Abramson DH, Schefler AC. Update on retinoblastoma. Retina 2004; 24: 828-848.
22. Shields CL, Mashayekhi A, Au AK, et al. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 2006; 113: 2276-2280.
23. Reese AB, Hyman GA, Merriam GR, Jr, et al. Treatment of retinoblastoma by radiation and triethylenemelamine. AMA Arch Ophthalmol 1954; 53: 505-513.
24. Mohri M. The technique of selective ophthalmic arterial infusion for conservative treatment of recurrent intraocular retinoblastoma [in Japanese]. Keio Igaku 1993; 70: 679-687.
25. Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol 2004; 9: 69-73.
26. Suzuki S, Kaneko A. Management of intraocular retinoblastoma and ocular prognosis. Int J Clin Oncol 2004; 9: 1-6.
27. Abramson DH, Dunkel IJ, Brodie SE, et al. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma. Ophthalmology 2008; 115: 1398-1404.
28. Abramson DH, Frank CM, Dunkel IJ. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma. Ophthalmology 1999; 106: 1947-1950.
29. Mendelsohn ME, Abramson DH, Madden T, et al. Intraocular concentrations of chemotherapeutic agents after systemic or local administration. Arch Ophthalmol 1998; 116: 1209-1212.
30. Abramson DH, Dunkel IJ, Brodie SE, et al. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology 2010; 117: 1623-1629.
31. Marr B, Gobin YP, Dunkel IJ, et al. Spontaneously resolving periocular erythema and ciliary madarosis following intra-arterial chemotherapy for retinoblastoma. Middle East Afr J Ophthalmol 2010; 17: 207-209.
32. Gobin YP, Dunkel IJ, Marr BP, et al. Intra-arterial chemotherapy for the management of retinoblastoma: Four-year experience. Arch Ophthalmol 2011; 129: 732-737.
33. Shields CL, Bianciotto CG, Jabbour P, et al. Intra-arterial chemotherapy for retinoblastoma: Report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol 2011; 129: 1399-1406.
34. Abramson DH, Dunkel IJ, Brodie SE, et al. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: Tandem therapy. Arch Ophthalmol 2010; 128: 370-372.
35. Brodie SE, Gobin YP, Dunkel IJ, et al. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma. Doc Ophthalmol 2009; 119: 13-22.
36. Murphree AL. Intraocular retinoblastoma: The case for a new group classification. Ophthal Clin N Am 2005; 18: 41-53.
37. Balaguer J, Wilson MW, Billups CA, et al. Predictive factors of invasion in eyes with retinoblastoma enucleated after eye salvage treatments. Pediatr Blood Cancer 2009; 52: 351-356.
38. Beck MN, Balmer A, Dessing C, et al. First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma. J Clin Oncol 2000; 18: 2881-2887.
39. Gündüz K, Günalp I, Yalçindag N, et al. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Ophthalmology 2004; 111: 1917-1924.
40. Shields CL, Honavar SG, Shields JA, et al. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol 2002; 120: 460-464.
41. Shields CL, Shields JA, DePotter P, et al. The effect of chemoreduction on retinoblastoma-induced retinal detachment. J Pediatr Ophthalmol Strabismus 1997; 34: 165-169.
42. Demirci H, Shields CL, Meadows AT, et al. Long-term visual outcome following chemoreduction for retinoblastoma. Arch Ophthalmol 2005; 123: 1525-1530.